Skip to content

Effects of monthly consumption of 100000 unit cholecalciferol during last third trimester of pregnancy on plasma iPTH and 25 (OH) D3 of the mother and cord blood

Determination of the effects of monthly consumption of 100000 unit cholecalciferol during third trimester on plasma iPTH and 25 (OH) D3 of the mother and offspring in a group of pregnant Tehranian women and a matched control group.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201104306335N1
Enrollment
25
Registered
2011-06-19
Start date
2009-06-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vit D. Fetus and newborn affected by maternal nutritional disorders

Interventions

Intervention 1: Cholecalciferol (Vitamin D3), capsule 50.000 IU, two capsules monthly for 3 months. Intervention 2: Distilled water capsule, two capsules monthly for 3 months in last trimester of preg
Treatment - Drugs
Placebo
Cholecalciferol (Vitamin D3), capsule 50.000 IU, two capsules monthly for 3 months
Distilled water capsule, two capsules monthly for 3 months in last trimester of pregnancy

Sponsors

Vice chancellor for endocrine research, Shahid Beheshty University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Pregnant women whose gestational age was between 27 to 28 weeks. Exclusion criteria: Patients with systemic diseases such as renal (Cr > 2) and known liver disease, sarcoidosis, tuberculosis and receiving of vit D and anticonvulsant drugs.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
25(0H)Vit D. Timepoint: 3 months. Method of measurement: Laboratory methods( ng/ml ).;IPTH. Timepoint: 3 months. Method of measurement: Laboratory methods(Pmol/l).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZary Sabet

Shahed University

sabet@shahed.ac.ir; sabet@safineh.net+98 21889661309

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026